Home » Topics » BioWorld Science

BioWorld Science
RSS

ArTara Therapeutics begins development of TARA-002

June 21, 2019

European Commission approves Esperoct for adolescents and adults with hemophilia A

June 21, 2019

Phase II proof-of-concept study of REGN-3500 in asthma meets primary endpoint

June 21, 2019

PAOPA displays varied antiparkinsonian activity in vivo

June 21, 2019

Orion's OB-002 equivalent to anti-PD-1 antibody in preclinical colorectal cancer model

June 21, 2019

Pancreatic cancer biomarker turns out to be disease driver

June 21, 2019

Distal motor neuropathy found associated with mutations in GBF1 gene

June 21, 2019

Chinese PLA General Hospital patents compositions comprising bacillus Oscillibacter valericigenes

June 21, 2019

Bristol-Myers Squibb, Allied-Bristol Life Sciences patent EPRS inhibitors

June 21, 2019

New creatine prodrugs disclosed by Ultragenyx Pharmaceutical

June 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...